Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
Status:
Terminated
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of fludarabine, Velcade, and
rituximab treatment regimen in patients with relapsed or refractory follicular non-Hodgkin
lymphoma.